Source: International Congress 2018 – Epidemiology of asthma and allergy: prevalence, incidence and risk factors
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Jansson (Umeå, Sweden), H. Backman (Umeå, Sweden), M. Andersson (Södertälje, Sweden), G. Telg (Södertälje, Sweden), A. Lindberg (Umeå, Sweden), B. Eklund (Umeå, Sweden), B. Lundbäck (Gothenburg, Sweden), E. Rönmark (Umeå, Sweden). Societal costs of severe asthma in Sweden. 1157

Member's Comments

No comment yet.

Related content which might interest you: Costs of COPD and asthma in Sweden Source: Eur Respir J 2004; 24: Suppl. 48, 701s Year: 2004 Costs of asthma care in Belgium Source: Eur Respir J 2001; 18: Suppl. 33, 441s Year: 2001 Extent of uncontrolled disease and associated medical costs in severe asthma in the Netherlands Source: Annual Congress 2007 - Epidemiology of asthma Year: 2007 The costs of adult asthma in Denmark Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD Year: 2011 Health care costs associated with acute asthma: a economic analysis Source: Eur Respir J 2002; 20: Suppl. 38, 42s Year: 2002 Health care utilization and costs of asthma and COPD in the Netherlands Source: Eur Respir J 2005; 26: Suppl. 49, 383s Year: 2005 Cost of health care associated with workplace exacerbation of asthma Source: Eur Respir J 2007; 30: Suppl. 51, 157s Year: 2007 Projections of future costs of asthma and COPD in the Netherlands Source: Eur Respir J 2005; 26: Suppl. 49, 383s Year: 2005 Social distancing and admissions for severe exacerbations of COPD – a nationwide study Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 Cost of asthma exacerbations managed in primary care in Spain Source: Eur Respir J 2001; 18: Suppl. 33, 329s Year: 2001 Main cost drivers of costs for asthma in society - report from the obstructive lung disease in Northern Sweden studies (OLIN) Source: Eur Respir J 2001; 18: Suppl. 33, 441s Year: 2001 Economic costs of severe asthma in omalizumab-treated patients. FENOMA Study Source: International Congress 2017 – Clinical points to ponder in asthma Year: 2017 Manner of treatment and costs of COPD exacerbations in secondary medical care in Poland Source: Eur Respir J 2007; 30: Suppl. 51, 194s Year: 2007 Active tobacco smoking and costs of COPD exacerbations in secondary medical care in Poland Source: Eur Respir J 2007; 30: Suppl. 51, 194s Year: 2007 Late Breaking Abstract - Assessing epidemiology and costs of asthma and COPD in Switzerland with health insurance data Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs Year: 2018 Trends in COPD-related hospitalisations in Sweden Source: Eur Respir J 2003; 22: Suppl. 45, 217s Year: 2003 Asthma: prevalence and cost of illness Source: Eur Respir J 2005; 25: 47-53 Year: 2005 Health care cost associated with acute and stable asthma: an economic analysis Source: Eur Respir J 2003; 22: Suppl. 45, 418s Year: 2003 The burden of illness and economic evaluation for COPD Source: Eur Respir J 2003; 21: 29S-35S Year: 2003